Back to Search
MOHAMAD ATTAL, DMD
DMD
Student in an Organized Health Care Education/Training Program
NPI: 1427805068Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
The role of high-dose therapy with autologous stem cell support in the era of novel agents.
PMID 19389496·Semin Hematol·2009
6-review
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).
PMID 19554029·Leukemia·2009
6-review
The level of AKT phosphorylation on threonine 308 but not on serine 473 is associated with high-risk cytogenetics and predicts poor overall survival in acute myeloid leukaemia.
PMID 19158829·Leukemia·2009
8-other
Higher incidence of relapse with peripheral blood rather than marrow as a source of stem cells in adults with acute myelocytic leukemia autografted during the first remission.
PMID 19597030·J Clin Oncol·2009
8-other
Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma.
PMID 18774632·Blood Rev·2009
6-review
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation.
PMID 19494840·Leukemia·2009
6-review
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.
PMID 19020545·Leukemia·2009
6-review
Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma.
PMID 19626046·Leukemia·2009
8-other
Posterior reversible encephalopathy syndrome: two cases in young adults with acute lymphoblastic leukemia.
PMID 18922579·Leuk Res·2009
5-case
Prediction of survival in multiple myeloma based on gene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: a study of the Intergroupe Francophone du Myélome.
PMID 18591550·J Clin Oncol·2008
8-other
Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure.
PMID 18799726·Blood·2008
4-observational
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma.
PMID 18094721·Leukemia·2008
6-review
Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
PMID 18346838·Exp Hematol·2008
4-observational
Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Société Francaise de Greffe de Moëlle et de Thérapie Cellulaire.
PMID 18390969·J Clin Oncol·2008
4-observational
Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow Transplantation.
PMID 18506024·J Clin Oncol·2008
8-other
Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group.
PMID 18268097·Blood·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5610 2ND AVE
BROOKLYN, NY 11220 - Phone
- (718) 630-7942
Quick Facts
- NPI
- 1427805068
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile